Dr. Karim Courtemanche, MD

Dr. Courtemanche practices at Sanford Medical Center - Bismarck in Bismarck, North Dakota.

Dr. Courtemanche's NPI, 1255827697, was assigned on July 9, 2018. Dr. Courtemanche holds North Dakota license 14913.

Dr. Courtemanche's primary practice is Sanford Medical Center - Bismarck, at 300 N 7th St, Bismarck, ND 58501 in Burleigh County. The practice phone is (701) 323-6000.

Dr. Courtemanche's primary practice is Sanford Medical Center - Bismarck in Bismarck, North Dakota. Dr. Courtemanche is also affiliated with Sanford Bismarck Medical Center. The medical group on file is Sanford Bismarck Medical Center. Dmand AI also links Dr. Courtemanche to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Courtemanche practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Courtemanche's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Courtemanche is licensed in North Dakota.

CMS data shows 785 Medicare services from Dr. Courtemanche across 11 procedure codes in 2024, for 487 Medicare patients. Medicare paid $60,662 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 487 Medicare patients who saw Dr. Courtemanche in 2024. The largest group is 65 to 74, with 249 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Courtemanche's median patient age at 74, with 26% women.

In 2024, Dr. Courtemanche wrote 1,055 Medicare Part D claims for 287 patients. 94% of them were for generic drugs. CMS names the drug for 978 of them, across 10 drugs with 11 or more claims each, at $41,177 in total drug cost. In 2023, CMS named 850 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Courtemanche for performance year 2024, reported as part of a group. Dr. Courtemanche accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Courtemanche as offering telehealth. CMS counts 23 procedures of prostate resection by Dr. Courtemanche, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Courtemanche, published from 2013 to 2019.

CMS Open Payments shows 75 general payments to Dr. Courtemanche from 34 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $307.